drugset / Trial / NCT02260180
Study of A-101 for the Treatment of Seborrheic Keratosis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety and dose-response of 2 concentrations of A-101 versus a vehicle control in the treatment of seborrheic keratosis.
Timeline
- Start
- 2014-10
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydrogen Peroxide | Small molecule | 32.5 % | Topical |
| Comparator | Hydrogen Peroxide | Small molecule | 40 % | Topical |